The SpaceX IPO Could Spark a "Risk-On" Rally: Here Are 2 Stocks That Could Benefit

SpaceX is set for a June 12 IPO at an implied valuation of about $1.77 trillion, down roughly $200 billion from a prior target, and the debut is being framed as a sentiment test for growth stocks. The article argues that a strong IPO could lift Micron, whose shares are up 898% over 12 months, and Rocket Lab, which is up about 74% year to date despite a recent pullback and now trades at roughly $70 billion market cap and 77x expected sales. The piece is speculative, but it highlights potential valuation ripple effects across space tech and broader risk-on sentiment.

Analysis

The key market mechanism here is not SpaceX itself, but the signaling effect on the public-growth multiple regime. A well-received debut would reinforce the idea that investors still tolerate extreme duration risk, which tends to compress risk premia across adjacent “story stock” cohorts and can mechanically lift high-beta names already embedded in momentum baskets. That matters most for names where valuation is sentiment-sensitive rather than purely cash-flow driven; the immediate beneficiaries are the closest public comparables and anything owned as a proxy for the private-space/AI innovation complex.

Micron’s linkage is more indirect but more powerful than the article implies: it is effectively a high-duration semiconductor beta surrogate now, with the market treating it as an AI infrastructure crowding trade. If SpaceX clears its first post-listing tests, the incremental effect is less about fundamentals and more about a broader de-risking of the “expensive growth can still work” narrative, which can extend multiple expansion for leaders that already have earnings torque. The second-order loser is not a named competitor, but any weak-balance-sheet small-cap growth issuer that has been surviving on scarcity value; those names usually underperform when a marquee IPO soaks up speculative capital without delivering a clean aftermarket pop.

For Rocket Lab, the setup is asymmetric because it has already absorbed a valuation reset tied to both event risk and competitive comparison. If SpaceX trades well, RKLB likely catches a sympathy bid, but the bigger issue is whether the IPO creates a higher bar for stand-alone space execution; investors may start demanding proof of durable margins and contract quality rather than just addressable-market stories. That means the upside from a successful IPO is likely quicker than the downside from a failed one, but the downside would linger for weeks as the market re-rates the entire sector against the new private-market reference point.

Key Decisions for Investors

• Long MU into the IPO window, but only via a 2-4 week tactical trade; use a stop if broader growth tape rolls over, because the upside is mostly sentiment-driven rather than event-specific.
• Buy RKLB on post-IPO weakness if SpaceX debuts well; 1-3 month horizon, looking for a sympathy re-rating toward the prior high, but size modestly given high multiple and event-risk reversals.
• If SpaceX trades strongly in the first 2-3 sessions, add NVDA/INTC exposure through semis basket rather than single-name chasing; the goal is to capture any broad risk-on spillover without overpaying for the IPO itself.
• Pair long MU / short a basket of unprofitable small-cap growth names for 1 month: if the IPO validates growth appetite, the market should reward real earnings torque while continuing to punish weak balance sheets.
• Avoid initiating fresh shorts in RKLB before the IPO print; the better entry is only after the market has confirmed whether the SpaceX signal is a one-day pop or a sustained sentiment regime shift.